US Stock MarketDetailed Quotes
NEVPF ABLIVA AB
- 0.010000
- 0.0000000.00%
15min DelayClose Mar 4 16:00 ET
10.56MMarket Cap-1428P/E (TTM)
0.000000High0.000000Low0Volume0.010000Open0.010000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)1.06BShares0.02000052wk High1.25P/B10.56MFloat Cap0.00000152wk Low--Dividend TTM1.06BShs Float0.150000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
About ABLIVA AB Company
Abliva AB operates as a biopharmaceutical company, which engages in the research and development of medicines for the treatment of primary mitochondrial diseases. Its projects include KL1333 and NV354. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden.
Company Profile
SymbolNEVPF
Company NameABLIVA AB
Founded2000
MarketPink Market
Employees9
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressMedicon Village,Scheeletorget 1
CityLund
ProvinceSkane
CountrySweden
Zip Code223 81
Phone46-46-275-62-20
Websitehttp://www.abliva.com
Company Executives
- Name
- Position
- Salary
- David Laskow-Pooley
- Chairman of the Board
- --
- Roger Franklin
- Director
- --
- Dr. Edwin Moses, B.Sc. ,PhD
- Independent Director
- --
- Denise Goode
- Independent Director
- --
- Jan Tornell
- Independent Director
- --
- David Bejker
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg